The Bradley Group would like to recognise the following research partners for their funding and financial support of our work.
Further information on our research funding can be found below and via this page.
ADREEM: Adding Another Dimension - Arrays of 3D Bio-Responsive materials
1/11/14 > 30/09/15
£1,711,766, EU government bodies
Smart materials for targeted stem cell fate and function in skeletal repair
31/03/14 > 30/03/17
HumEn Project (RTD)
Bickmore, W. & Bradley, M.
1/01/14 > 31/12/17
£828,061, EU government bodies
IMAGFIB: Imaging Fibrosis - Chemistry and Optical Confocal Laser Endomicroscopy
1/10/13 > 30/09/15
£171,321, EU government bodies
Multiplexed 'Touch and Tell' Optical Molecular Sensing and Imaging
Bradley, M., Henderson, R., Dhaliwal, K., Haslett, C. & Williams, C.
1/10/13 > 30/09/18
CLEDEPOLY: Tissue Specific Delivery via Cleavable and Degradable Polymers
1/07/13 > 30/06/15
£164,153, EU government bodies
Implantable Microsystems for Personalised Anti-Cancer Therapy
Murray, A., Walton, A., Bradley, M., Argyle, D., Smith, S., Tait, J. & Haddow, G.
27/05/13 > 26/05/18
A new paradigm for testing pathway tractability in lung disease
Hirani, N., Dhaliwal, K., Haslett, C. & Bradley, M.
1/05/13 > 30/04/16
Chemical Strategies for Epigenome wide discrimination of 5-hydroxymethylcytosine and 5-methylcytosine
Bradley, M. & De Sousa, P.
1/11/12 > 31/10/15
Molecular Optical Imaging of Key Targets in the Fibrogenic Pathway in Man
Bradley, M., Dhaliwal, K., Haslett, C., Hirani, N. & McGorum, B.
1/09/12 > 31/12/15